ORLANDO, Florida — Use of cannabis is common in patients with multiple sclerosis (MS), especially for the treatment of MS-related spasticity, new research suggests. Findings from a survey conducted ...

Being diagnosed with multiple sclerosis can, naturally, have an enormous impact on your life. You may need to make some lifestyle changes and try a few treatments to help manage the various symptoms, ...

NASHVILLE, Tennessee — As patient demand for cannabis treatment of multiple sclerosis (MS) rises with loosening medical marijuana laws, patients report benefits that even include the ability to reduce ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes. PHILADELPHIA — Real ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Dec. 5 -- FRIDAY, Dec. 4 (HealthDay News) -- Cancer patients, glaucoma patients and others can benefit from medical marijuana, and now a new analysis shows that it can help multiple sclerosis (MS) ...

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said Tuesday that phase 3 RELEASE MSS1 trial, which evaluated nabiximols oromucosal spray on clinical measures of spasticity in individuals with multiple ...

CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of ...

Credit: Getty Images. The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis. Topline results were announced from a phase 3 trial evaluating the ...

Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity ...

If you are one of the 2.5 million people worldwide living with multiple sclerosis, you likely already know some of the challenges of staying active with the condition. Hearing the words “you have MS” ...